Abstracto

COVID-19 and muscular involvement in neuromuscular diseases

Scouiller Knak

COVID-19, caused by SARS-CoV-2, has emerged as a global health crisis with widespread impacts on multiple organ systems. In addition to respiratory complications, there is emerging evidence of muscular involvement in COVID-19 patients, particularly in individuals with pre-existing neuromuscular diseases. This abstract summarizes the current understanding of the interaction between COVID-19 and neuromuscular diseases, highlighting the potential exacerbation of muscle weakness, myopathy, and neuromuscular junction dysfunction. We discuss the implications of COVID-19 on disease progression, management strategies, and the need for further research to better comprehend the intricate interplay between SARS-CoV-2 infection and neuromuscular conditions.